Search results
Luxa Biotechnology Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W...
Benzinga· 22 hours agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New ...
UMSOM Preclinical Study Finds Novel Stem Cell Therapy Boosts Neural Repair After Cardiac Arrest
Newswise· 1 day agoBrain injury is the most common consequence of cardiac arrest, due to the impaired blood flow and oxygen to the brain. About 70 percent of the nearly 7 million people who suffer from cardiac ...
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Newswise· 3 days agoWhen people think of Alzheimer’s Disease and possible treatment, amyloid — and the accumulation of plaques that invade the cerebral cortex — is often brought up first. By transplanting human ...
USC Scientists Rewrite Kidney Research With Groundbreaking Cell Cultivation
SciTechDaily· 2 days agoResearchers at USC have advanced kidney research by developing a new method to cultivate nephron progenitor cells from human stem cells. This method simplifies ...
$2.7 million grant to explore hypoxia’s impact on blood stem cells
Newswise· 6 days agoINDIANAPOLIS — Indiana University School of Medicine scientists are on a mission to understand why...
Sex and gender discussions don't need to be toxic
Nature· 1 day agoThe science of sex and gender is too often misinterpreted and weaponized. Now, three experts cut through the misinformation in search of a positive...
Anova to Manage Study of DB107 Following Newly Awarded $11.8M CIRM Grant
Benzinga· 23 hours agoAnova to manage delivery of Phase 1/2a study of DB107 at UCSF, USC, UCSD and with Denovo Biopharma DB107 is a proprietary gene therapy platform for the treatment of patients with newly diagnosed high grade
Some of us have a uniquely human gene that enhances immune function
UB Reporter· 1 day ago“The immune system needs a road to get into infected tissue,” she adds, “and the CHRFAM7A cells developed a new mechanism: They can cut through the extracellular matrix, or fabric of the organs ...
Cell and gene therapy companies trip at scalability hurdle
Pharmaceutical Technology via Yahoo Finance· 3 days agoBefore its discontinuation, the company had raised $100 million in a Series B funding round....
NovAccess Global Announces New License to Advance its Immunotherapy Platform
Digital Journal· 2 days agoCLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients suffering from cancers of the central nervous ...